- Home
- CRGY vs BHC Comparison
CRGY vs BHC Comparison
Compare CRGY & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGY | BHC |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.5B |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CRGY | BHC |
|---|---|---|
| Price | $11.77 | $5.33 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $13.25 | $8.33 |
| AVG Volume (30 Days) | ★ 8.1M | 2.5M |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | ★ 4.06% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | $3,579,782,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $26.77 | $4.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $99.08 | ★ $12.85 |
| Revenue Growth | ★ 22.14 | N/A |
| 52 Week Low | $6.83 | $4.28 |
| 52 Week High | $12.40 | $8.69 |
Technical Indicators
Market Signals| Indicator | CRGY | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 63.61 | 31.86 |
| Support Level | $8.29 | N/A |
| Resistance Level | $12.40 | $7.22 |
| Average True Range (ATR) | 0.57 | 0.22 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 75.75 | 15.25 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The Company's investing and operating activities are focused in Texas and the Rocky Mountain region.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.